Twist Bioscience

Twist Bioscience
TypePublic
Industrysynthetic biology
Founded2013; 13 years ago (2013)
Founders
Headquarters
ProductsGenes and gene fragments, NGS products
RevenueIncrease US$459.4 million (2026)
Decrease US$−130.2 million (2026)
Number of employees
400
Websitetwistbioscience.com

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.

The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.

In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.